EENT · PANCE / PANRE

Acute Otitis Media (AOM)

Acute middle ear infection with effusion and signs of inflammation, most common in young children.

Also known as: AOM, middle ear infection, ear infection, suppurative otitis media

Overview

Acute infection of the middle ear cleft characterized by middle ear effusion (MEE) plus rapid onset of signs and symptoms of middle ear inflammation. Distinguished from otitis media with effusion (OME), which lacks acute inflammatory signs.

Epidemiology

Most common bacterial infection of childhood; peak incidence 6-24 months. By age 3, ~80% of children have had at least one episode. Risk highest in fall/winter following viral URI.

Try two board-style Acute Otitis Media questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1EENTEasy
A 3-year-old boy has ear pain and fever to 39.5°C. Examination shows bilaterally bulging, erythematous tympanic membranes. Which of the following is the most appropriate treatment?
  • AOral azithromycin suspension
  • BWatchful waiting for 48–72 hours
  • CHigh-dose oral amoxicillin
  • DCiprofloxacin otic drops
  • ETympanostomy tube placement
Reveal answer & full explanation
Correct answer: C — High-dose oral amoxicillin
  • AOral azithromycin suspension
  • BWatchful waiting for 48–72 hours
  • CHigh-dose oral amoxicillin✓
  • DCiprofloxacin otic drops
  • ETympanostomy tube placement

Why High-dose oral amoxicillin is correct

  • Bulging, erythematous tympanic membranes with otalgia and fever indicate acute otitis media; the fever of 39.5°C (≥39°C) makes this severe disease (bilateral involvement alone does not define severity)
  • Per American Academy of Pediatrics guidance, severe acute otitis media warrants immediate antibiotics regardless of age, and high-dose amoxicillin (80-90 mg/kg/day) is first-line when the child has not recently taken amoxicillin and has no penicillin allergy
  • Amoxicillin-clavulanate or intramuscular ceftriaxone is used for treatment failure at 48-72 hours; cefdinir, cefuroxime, or cefpodoxime is an alternative in non-severe penicillin allergy, while macrolides such as azithromycin are a poor last resort because of high resistance

Why the others are wrong

  • Tympanostomy tube placement — reserved for recurrent acute otitis media or persistent effusion, not a first acute episode; the right-condition-wrong-step trap
  • Ciprofloxacin otic drops — appropriate for otitis externa or otorrhea through a perforation or tube, but topical drops do not treat infection behind an intact bulging membrane; buzzword-match on "ear drops"
  • Watchful waiting for 48–72 hours — an option only for non-severe acute otitis media without high fever, so the severe fever here excludes it; premature closure on the observation strategy
  • Oral azithromycin suspension — once-daily dosing and a short course make it a tempting choice for a febrile toddler, but macrolides have limited efficacy against the main acute otitis media pathogens (pneumococcal macrolide resistance is high, and Haemophilus influenzae is intrinsically less susceptible, so azithromycin eradicates it poorly), making azithromycin a poor last resort, not first-line therapy for a child with no known penicillin allergy; the convenience-over-coverage trap
Question 2EENTEasy
A 3-year-old boy who attends daycare has had 4 episodes of acute otitis media this year, each with sudden ear pain, fever, and a bulging erythematous tympanic membrane. The current episode began yesterday with severe left ear pain and a temperature of 39.4 C (102.9 F), and each prior episode resolved with amoxicillin, most recently 5 months ago. He has no penicillin allergy. Which of the following is the most appropriate first-line treatment for this episode?
  • AHigh-dose amoxicillin
  • BObservation
  • CAmoxicillin-clavulanate
  • DTopical fluoroquinolone otic drops
  • EIntravenous ceftriaxone
Reveal answer & full explanation
Correct answer: A — High-dose amoxicillin
  • AHigh-dose amoxicillin✓
  • BObservation
  • CAmoxicillin-clavulanate
  • DTopical fluoroquinolone otic drops
  • EIntravenous ceftriaxone

Why High-dose amoxicillin is correct

  • Acute otitis media (AOM) is the most common bacterial infection in children
  • Diagnostic criteria: bulging tympanic membrane (most important finding), acute onset, and middle ear effusion
  • Common pathogens: S. pneumoniae, H. influenzae (most common in recurrent AOM), and M. catarrhalis
  • First-line treatment: amoxicillin 80-90 mg/kg/day for 5-10 days
  • Severe AOM (moderate or severe otalgia, otalgia for 48 hours or more, or a temperature of 39 C or higher) warrants immediate antibiotics at any age; this child's 39.4 C fever and severe ear pain qualify, and because prior episodes responded to amoxicillin and none was given in the past 30 days, amoxicillin remains first-line (otherwise amoxicillin-clavulanate)

Why the others are wrong

  • Observation — an option only for non-severe AOM (unilateral disease at 6-23 months, unilateral or bilateral disease at 2 years or older) with shared decision-making and reliable follow-up; a temperature of 39 C or higher and severe otalgia define severe AOM, which requires antibiotics (confused-with watchful waiting)
  • Topical fluoroquinolone otic drops — used for otitis externa or AOM with tympanostomy tubes, not intact-membrane AOM (right-concept-wrong-route)
  • Intravenous ceftriaxone — reserved for treatment failure or when oral therapy is not tolerated; not first-line (premature escalation)
  • Amoxicillin-clavulanate — tempting because this daycare child has recurrent AOM and H. influenzae often produces beta-lactamase, but added beta-lactamase coverage is reserved for amoxicillin use in the past 30 days, concurrent purulent conjunctivitis, or recurrent AOM unresponsive to amoxicillin; every prior episode here responded and the last course was 5 months ago (over-treating recurrence)

Additional high-yield points

  • Treatment failure (no improvement at 48-72 hours): switch to amoxicillin-clavulanate
  • Tympanostomy tube indications: recurrent AOM (3 episodes in 6 months, or 4 in 12 months with at least 1 in the past 6 months) only when middle ear effusion is present at the time of assessment; bilateral otitis media with effusion for 3 months or longer with documented hearing difficulty
  • Tympanostomy tubes give a modest, short-term reduction in AOM frequency

That's 2. Get 7,700+ more.

Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial →
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Acute Otitis Media (AOM) outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Age <2 years (short, horizontal eustachian tube)
  • Daycare attendance, exposure to tobacco smoke
  • Bottle-propping, pacifier use beyond 6 months
  • Absence of breastfeeding (breastfeeding ≥6 months is protective)
  • Craniofacial anomalies (cleft palate, Down syndrome)
  • Family history of recurrent AOM
  • Native American, Alaskan Native, and Australian Aboriginal ancestry

Pathophysiology

Viral URI causes eustachian tube dysfunction and mucosal edema, impairing middle ear drainage. Negative pressure draws nasopharyngeal secretions retrograde into the middle ear, where bacterial pathogens proliferate in the resulting effusion. Common bacterial pathogens: Streptococcus pneumoniae, non-typeable Haemophilus influenzae, Moraxella catarrhalis. Viruses (RSV, rhinovirus) may be the sole pathogen.

Clinical presentation

Symptoms

  • Ear pain (otalgia) — pulling/tugging at ear in preverbal children
  • Fever, irritability, poor feeding, disrupted sleep
  • Preceding URI symptoms (rhinorrhea, cough)
  • Hearing loss; otorrhea if TM has perforated
  • In older children/adults: localized pain, sensation of ear fullness

Signs / physical exam

  • Bulging tympanic membrane — most specific sign
  • Loss of bony landmarks; opacification; yellow, white, or hemorrhagic color
  • Impaired TM mobility on pneumatic otoscopy
  • Air-fluid level or bubbles behind TM (confirms effusion, also seen in OME; not diagnostic of AOM without bulging or acute inflammation)
  • Otorrhea through a perforation

Classic findings

Bulging, opacified TM with impaired mobility on pneumatic otoscopy in a febrile child with otalgia.

Differential diagnosis

  • Otitis media with effusion (OME) — Middle ear effusion without acute inflammatory signs; usually painless; hearing loss; no fever; observation appropriate
  • Otitis externa — Pain on tragal pressure or pinna traction, erythematous swollen canal with debris, normal TM if visible; treat with topical otic drops
  • Bullous myringitis — Painful bullae on TM; classically Mycoplasma but most often pneumococcus; treat as AOM
  • Mastoiditis — Postauricular erythema, swelling, fluctuance, protruding auricle, fever; CT temporal bone confirms; IV antibiotics ± surgical drainage
  • Foreign body in ear canal — Unilateral pain or discharge, often in toddlers; direct visualization; removal under microscopy
  • Dental pain referred — Posterior molar caries can refer pain to ear; normal otoscopy
  • TMJ dysfunction — Preauricular pain, clicking with jaw motion, normal TM

Diagnostic workup

Diagnostic criteria

AAP 2013: (1) Moderate-to-severe bulging of TM or new-onset otorrhea not due to otitis externa, OR (2) mild bulging with recent (<48 h) onset of ear pain or intense erythema of TM. Middle ear effusion must be present.

Labs

  • AOM is a clinical diagnosis; laboratory testing is rarely needed
  • Tympanocentesis with culture reserved for treatment failure, immunocompromised, or neonates

Imaging

  • Pneumatic otoscopy or tympanometry — confirms middle ear effusion when otoscopy ambiguous
  • CT temporal bone if mastoiditis, intracranial complication, or cholesteatoma suspected

Diagnostic algorithm

Age / SeverityAntibiotic DecisionPreferred Agent
<6 months, any severityAntibiotics alwaysAmoxicillin or amox-clav
6-23 months, bilateral or severeAntibiotics alwaysAmoxicillin 80-90 mg/kg/day
6-23 months, unilateral non-severeAntibiotics OR 48-72 h observationAmoxicillin if treating
≥24 months, severe (moderate-severe otalgia, otalgia ≥48 h, or T ≥39°C) or otorrheaAntibiotics alwaysAmoxicillin or amox-clav
≥24 months, non-severeAntibiotics OR observation with follow-upAmoxicillin if treating
Any age, treatment failure at 48-72 hSwitch antibioticAmoxicillin-clavulanate or ceftriaxone IM
AAP 2013 management algorithm for acute otitis media by age, severity, and treatment response.

Treatment

First-line

  • Amoxicillin 80-90 mg/kg/day divided BID × 10 days if <2 y or severe (7 days if 2-5 y and non-severe; 5-7 days if ≥6 y and non-severe) — preferred if no amoxicillin in prior 30 days, no concurrent purulent conjunctivitis, and no history of recurrent AOM unresponsive to amoxicillin
  • Amoxicillin-clavulanate 90 mg/kg/day amoxicillin component if any of the above risk factors are present, or for treatment failure at 48-72 h
  • Analgesia: acetaminophen or ibuprofen — addressed independently of antibiotic decision
  • Observation option (deferred antibiotics, reassess 48-72 h) for non-severe AOM (mild otalgia <48 h and T <39°C) in children ≥6 months without otorrhea (unilateral only at 6-23 months) — requires reliable follow-up

Second-line / adjunct

  • Cefdinir, cefuroxime, or cefpodoxime for non-anaphylactic penicillin allergy
  • Azithromycin or clindamycin for severe penicillin allergy (high resistance — use only when alternatives unavailable)
  • Ceftriaxone IM 50 mg/kg daily × 1-3 days for vomiting or oral intolerance
  • Tympanostomy tubes: recurrent AOM (≥3 episodes in 6 months, or ≥4 in 12 months with ≥1 in the past 6 months) only if middle ear effusion is present at assessment; bilateral OME ≥3 months with documented hearing difficulty

Complications

  • TM perforation (usually heals spontaneously)
  • Mastoiditis — postauricular swelling, requires IV antibiotics ± mastoidectomy
  • Intracranial: meningitis, brain abscess, lateral sinus thrombosis
  • Cholesteatoma from chronic perforation or retraction pocket
  • Conductive hearing loss with speech/language delay if persistent effusion
  • Facial nerve palsy (rare, traverses middle ear)

PANCE pearls

  • Bulging TM is the single most important finding — erythema alone is nonspecific (crying can cause it).
  • AOM in any child <6 months → always treat with antibiotics. Ages 6-24 months: treat if bilateral, severe, or otorrhea; otherwise observation option.
  • Concurrent purulent conjunctivitis suggests non-typeable H. influenzae → use amoxicillin-clavulanate.
  • PCV13/PCV15/PCV20 vaccination has shifted pathogen epidemiology — H. influenzae now equals or exceeds S. pneumoniae in many settings.
  • Recurrent AOM = ≥3 episodes in 6 months or ≥4 in 12 months (≥1 in the past 6 months) — offer tympanostomy tubes only if middle ear effusion is present at assessment.

References

  • AAP 2013 — Lieberthal AS et al. The diagnosis and management of acute otitis media. Pediatrics 2013;131(3):e964-e999
  • AAO-HNS 2022 — Rosenfeld RM et al. Clinical Practice Guideline: Tympanostomy Tubes in Children (Update). Otolaryngol Head Neck Surg 2022
  • Coker 2010 (JAMA) — Coker TR et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA 2010;304(19):2161-2169

Practice EENT questions on FirstPassPA

Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start your 7-day free trial → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.